Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

AGM Statement

19 Jun 2013 07:00

RNS Number : 3441H
Impellam Group plc
19 June 2013
 

IMPELLAM GROUP PLC

 

Annual General Meeting - Trading update 19th June 2013

 

Impellam Group plc ("Impellam" or "the Group") will issue the following trading update at today's Annual General Meeting.

 

"Trading in the first five months of 2013 has been broadly in line with the Board's expectations. Our United Kingdom and North America Staffing businesses are both reporting increased activity and growth in net fee income, year over year. Our North America business returned to year on year net fee income growth in Q2 of 2012 and we expect the United Kingdom business to report similar growth in Q2 this year. Both businesses are also reporting increases in EBITDA when compared to prior year periods as a result of both net fee income growth and improvements in efficiency.

 

However, our Medacs Healthcare business is seeing challenging market conditions with volumes and net fee income under pressure. We are also seeing increased costs associated with both enhanced compliance requirements and in the sourcing of the required medical professionals for the demand available. We therefore expect to see both net fee income and EBITDA compression in the first half.

 

Our Carlisle Support Services business is also continuing to see little or no recovery in demand in the retail market. In addition, costs associated with the mobilisation of recent contract wins are depressing gross margin percentages compared to prior periods.

 

However, there will be no repeat of the prior year restructuring charges.

 

Accordingly, in the first half of the year, unadjusted earnings per share are expected to be broadly flat compared to the prior year."

 

Impellam expects to publish trading results for the 26 weeks to 28th June 2013 on 25th July 2013.

 

 

Enquiries: For further information please contact the appropriate individual below.

 

Impellam Group plc

Andrew Wilson Tel: 01582 692658

Julia Roberton Tel: 01582 692658

Andrew Burchall Tel: 01582 692658

 

Cenkos Securities plc

(Nominated Advisor and Broker to Impellam)

Nicholas Wells Tel: 020 7397 8900

Elizabeth Bowman

Note to Editors:

Impellam Group plc conducts business primarily in the UK and North America, with smaller operations in Australia, Ireland, New Zealand and mainland Europe. The Group employs nearly 6,000 people, including 2,200 managers and consultants and more than 3,500 support services workers, across a network of 230 branch and regional offices. The Group operates more than 15 specialty brands across a broad range of staffing sectors which are complemented by businesses in the outsourced support services sector. Impellam Group is ranked 19th on the Staffing Industry Analysts' 2012 Top Global Staffing Companies List.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMUWRAROOANAUR
Date   Source Headline
17th Feb 20239:29 amRNSForm 8.5 (EPT/RI)
16th Feb 20233:00 pmRNSForm 8.3 - Impellam Group plc
16th Feb 202310:13 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
15th Feb 202310:44 amRNSForm 8.5 (EPT/RI)
15th Feb 20237:01 amRNSRule 2.9 Announcement
15th Feb 20237:00 amRNSTransaction in Own Shares
14th Feb 202310:00 amRNSTransaction in Own Shares
14th Feb 202310:00 amRNSRule 2.9 Announcement
14th Feb 20239:14 amRNSForm 8.5 (EPT/RI)
10th Feb 202310:51 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
10th Feb 20237:01 amRNSRule 2.9 Announcement
10th Feb 20237:00 amRNSTransaction in Own Shares
9th Feb 202311:09 amRNSForm 8.5 (EPT/RI)
9th Feb 20239:16 amRNSRule 2.9 Announcement
9th Feb 20239:15 amRNSTransaction in Own Shares
8th Feb 20239:30 amRNSRule 2.9 Announcement
8th Feb 20239:30 amRNSTransaction in Own Shares
8th Feb 20237:17 amRNSForm 8.5 (EPT/RI)
6th Feb 20232:16 pmRNSRule 2.9 Announcement
6th Feb 20232:15 pmRNSTransaction in Own Shares
6th Feb 202311:32 amRNSRule 2.9 Announcement
6th Feb 202311:30 amRNSTransaction in Own Shares
6th Feb 202310:02 amRNSForm 8.5 (EPT/RI)
2nd Feb 202311:24 amRNSForm 8.5 (EPT/RI)
31st Jan 202310:41 amRNSForm 8.5 (EPT/RI)
31st Jan 20237:00 amRNSRule 2.9 Announcement
31st Jan 20237:00 amRNSTransaction in Own Shares
30th Jan 20237:00 amRNSDisposal and Trading Update
20th Jan 202311:08 amRNSForm 8.5 (EPT/RI)
20th Jan 20237:00 amRNSRule 2.9 Announcement
20th Jan 20237:00 amRNSTransaction in Own Shares
18th Jan 202310:54 amRNSForm 8.3 - Impellam Group plc
18th Jan 202310:00 amRNSRule 2.9 Announcement
18th Jan 202310:00 amRNSTransaction in Own Shares
18th Jan 20238:59 amRNSForm 8.5 (EPT/RI)
16th Jan 202311:11 amRNSForm 8.3 - Impellam Group plc
16th Jan 202311:00 amRNSRule 2.9 Announcement
16th Jan 202311:00 amRNSTransaction in Own Shares
16th Jan 202310:40 amRNSForm 8.5 (EPT/RI)
13th Jan 202311:28 amRNSForm 8.5 (EPT/RI)
13th Jan 202310:00 amRNSRule 2.9 Announcement
13th Jan 202310:00 amRNSTransaction in Own Shares
12th Jan 202310:47 amRNSForm 8.3 - Impellam Group PLC
12th Jan 20238:57 amRNSForm 8.5 (EPT/RI)
12th Jan 20237:00 amRNSRule 2.9 Announcement
12th Jan 20237:00 amRNSTransaction in Own Shares
11th Jan 202310:04 amRNSForm 8.5 (EPT/RI)
10th Jan 202312:25 pmRNSForm 8.3 - Impellam Group PLC
10th Jan 20239:25 amRNSForm 8.5 (EPT/RI)
9th Jan 202311:46 amRNSForm 8.3 - Impellam Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.